Hypertrophic Cardiomyopathy Rare in Elite Athletes

Article

New research suggests that routine echocardiographic screening of elite athletes to detect hypertrophic cardiomyopathy (HCM) may not be warranted, as HCM is extremely rare in this population, according to an article published in the March 11 issue of the Journal of the American College of Cardiology.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
David Brousseau, MD, highlights impact of timely opioid dosing in pediatric sickle cell pain
August's FDA Focus: Approvals and pipeline updates in pediatrics | Image credit: Contemporary Pediatrics
© 2025 MJH Life Sciences

All rights reserved.